BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 10, 2010
 |  BC Week In Review  |  Company News  |  Other News

Merck neurology news

Merck said the U.S. Supreme Court ruled that shareholder ligation accusing Merck of securities fraud related to the pain drug Vioxx rofecoxib was filed within the statute of limitations. The decision affirms a 2008 ruling by the U.S....

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >